Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Surg Innov ; 31(2): 220-223, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38387870

ABSTRACT

BACKGROUND: Precise preoperative localization of liver tumors facilitates successful surgical procedures, Intraoperative ultrasonography is a sensitive imaging modality. However, the presence of small non-palpable isoechoic intraparenchymal lesions may be challenging intraoperatively. METHODOLOGY AND MATERIAL DESCRIPTION: Onyx® is a non-adhesive liquid agent comprised of ethylene-vinyl alcohol usually used dissolved in dimethyl-sulfoxide and suspended micronized tantalum powder to provide contrast for visualization under fluoroscopy and ultrasonography and a macroscopic black shape. This embolization material has been increasingly used for the embolization of intracranial arteriovenous malformations. We present the novel application of Onyx® on liver surgery. CURRENT STATUS: We present the case of a female, 55 years-old, whose medical history revealed an elective sigmoidectomy (pT3N1a). After 17 months of follow up, by PET-CT scan, the patient was diagnosed of a small intraparenchymal hypo-attenuated 13 mm tumor located at segment V consistent with metachronous colorectal liver metastasis. Open metastasectomy was performed, ultrasonography-guided Onyx® infusion was delivered the day after, intraoperative ultrasonography showed a palpable hyperechoic material with a posterior acoustic shadowing artifact around the lesion. Onyx® is a promising new tool, without any previous application on liver surgery, feasible with advantages in small not palpable intraparenchymal liver lesions.


Subject(s)
Embolization, Therapeutic , Liver Neoplasms , Female , Humans , Middle Aged , Embolization, Therapeutic/methods , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/surgery , Polyvinyls/therapeutic use , Positron Emission Tomography Computed Tomography , Treatment Outcome
2.
Updates Surg ; 76(2): 565-571, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38316738

ABSTRACT

Textbook outcome is a multidimensional quality management tool that uses a set of traditional surgical measures to reflect an "ideal" surgical result for a particular pathology. Retrospective study of all patients undergoing scheduled for adrenal tumors surgery at an endocrine surgery unit from January 2010-December 2022. The definition of Textbook Outcome were: R0 resection, no Clavien-Dindo ≥ IIIa complications, no prolonged stay (< P75), no readmissions, and no mortality in the first 30 days. The main objective was to analyze the rate of Textbook Outcome obtained. One hundred and five patients were included in the study. Textbook Outcome was achieved in 71.4%. Surgical approach (p < 0.001), Charlson scale (p = 0.031), American Society of Anesthesiologists Classification (p = 0.047) and surgical time (p < 0.001) were all significantly associated with the achievement of Textbook Outcome. The laparoscopic approach was associated as an independent factor with obtaining Textbook Outcome (OR:5.394; p = 0.016), as was surgical time (OR:0.986; p = 0.004). Textbook Outcome is a novel, useful, easy-to-interpret tool for measuring results in adrenal surgery. The laparoscopic approach is associated with a higher rate of "ideal" surgical results. The study was registered in the public accessible database clinicaltrials.gov with the ClinicalTrials.gov ID: NCT05888753.


Subject(s)
Adrenal Gland Neoplasms , Laparoscopy , Humans , Adrenalectomy/methods , Retrospective Studies , Adrenal Gland Neoplasms/surgery , Adrenal Gland Neoplasms/pathology , Postoperative Complications/etiology , Laparoscopy/methods , Treatment Outcome
3.
Updates Surg ; 75(4): 905-914, 2023 Jun.
Article in English | MEDLINE | ID: mdl-36991301

ABSTRACT

Laparoscopic cholecystectomy is the gold standard for the treatment of acute cholecystitis (AC). Percutaneous cholecystostomy (PC) for management of AC is increasing; safe and less invasive than laparoscopic cholecystectomy and is very useful in selected patients with severe comorbidities, not suitable for surgery/general anesthesia. We conducted a retrospective observational study between 2016 and 2021 of patients treated with PC for AC, based on the application of the Tokyo guidelines 13/18. The aim was to analyse the clinical results and management of PC in patients undergoing elective or emergency cholecystectomy. Subsequently, a retrospective analytical study was designed to compare various cohorts: elective or emergency surgery and management with PC alone; patients with/without a high surgical risk; and elective vs emergency surgery. Hundred and ninety five patients with AC were treated with PC. Mean age was 74 years, 59.5% were ASA class III/IV, and the mean Charlson comorbidity index was 5.5. Adherence to Tokyo guidelines regarding indication of PC was 50.8%. The rate of complications associated to PC was 12.3% and the 90-day mortality rate was 14.4%. Mean length of time using PC was 10.7 days. Emergency surgery was performed in 4.6%. The overall success rate using PC was 66.7%, and the 1-year readmission rate due to biliary complications after PC was 28.2%. The rate of scheduled cholecystectomy after PC was 22.6%. Conversion to laparotomy and open approach was more frequent in patients who underwent emergency surgery (p = 0.009). No differences were found in 90-day mortality or in the complication rate. PC achieves improvements in the inflammation and infection associated with AC. In our series, it proved to be an effective and safe treatment during the acute episode of AC. Mortality in patients treated with PC is high due to their older age, greater morbidity, and higher Charlson comorbidity index scores. After PC, emergency surgery is uncommon but readmission due to biliary events is high. Cholecystectomy after PC is the definitive treatment and the laparoscopic approach is feasible. Clinical trial registery: The study was registered in the public accessible database clinicaltrials.gov with the ClinicalTrials.gov ID: NCT05153031. Public release date: 12/09/2021.


Subject(s)
Cholecystectomy, Laparoscopic , Cholecystitis, Acute , Cholecystostomy , Humans , Aged , Cholecystostomy/adverse effects , Cholecystostomy/methods , Retrospective Studies , Cholecystitis, Acute/surgery , Cholecystitis, Acute/etiology , Cholecystectomy/methods , Cholecystectomy, Laparoscopic/adverse effects , Treatment Outcome
4.
ACS Appl Mater Interfaces ; 12(48): 53869-53878, 2020 Dec 02.
Article in English | MEDLINE | ID: mdl-33205967

ABSTRACT

Hybrid redox flow cells (HRFC) are key enablers for the development of reliable large-scale energy storage systems; however, their high cost, limited cycle performance, and incompatibilities associated with the commonly used carbon-based electrodes undermine HRFC's commercial viability. While this is often linked to lack of suitable electrocatalytic materials capable of coping with HRFC electrode processes, the combinatory use of nanocarbon additives and carbon paper electrodes holds new promise. Here, by coupling electrophoretically deposited nitrogen-doped graphene (N-G) with carbon electrodes, their surprisingly beneficial effects on three types of HRFCs, namely, hydrogen/vanadium (RHVFC), hydrogen/manganese (RHMnFC), and polysulfide/air (S-Air), are revealed. RHVFCs offer efficiencies over 70% at a current density of 150 mA cm-2 and an energy density of 45 Wh L-1 at 50 mA cm-2, while RHMnFCs achieve a 30% increase in energy efficiency (at 100 mA cm-2). The S-Air cell records an exchange current density of 4.4 × 10-2 mA cm-2, a 3-fold improvement of kinetics compared to the bare carbon paper electrode. We also present cost of storage at system level compared to the standard all-vanadium redox flow batteries. These figures-of-merit can incentivize the design, optimization, and adoption of high-performance HRFCs for successful grid-scale or renewable energy storage market penetration.

5.
Endocrinol. nutr. (Ed. impr.) ; 56(8): 428-430, oct. 2009.
Article in Spanish | IBECS | ID: ibc-78735

ABSTRACT

El síndrome de Pendred es un trastorno de herencia autosómica recesiva, que cursa con pérdida de la audición neurosensorial y con un grado variable de bocio por trastornos en la organificación del yodo. Surge de alteraciones en una proteína transmembrana del borde apical de la célula tiroidea, denominada pendrina, que se encuentra también en el riñón y el oído interno. El estudio genético de estos pacientes permite identificar a otros miembros afectos, realizar un consejo genético adecuado y un cribado precoz en sus descendientes. Presentamos el caso de 2 hermanos, afectos de sordera neurosensorial, diagnosticados de síndrome de Pendred en la edad adulta al consultar uno de ellos por bocio (AU)


Pendred’s syndrome is an autosomal recessive disorder leading to congenital sensorineural hearing loss and a variable degree of goiter due to reduced iodine organification. The cause of this disease is dysfunction of an anion transporter protein located on the apical membrane of thyrocytes, called pendrin, which is also found in the kidney and cochlea. Molecular analysis of the gene is useful to identify other affected family members and provide proper genetic advice and early diagnosis in descendants. We present the cases of two siblings with sensorineural deafness who were diagnosed with Pendred’s syndrome as adults because one of them consulted for goiter (AU)


Subject(s)
Humans , Male , Adult , Goiter/genetics , Hearing Loss, Sensorineural/genetics , Membrane Transport Proteins/genetics , Biological Transport/genetics , Endolymph/methods , Genes, Recessive , Hearing Loss, Sensorineural/congenital , Incidental Findings , Kidney/methods , Membrane Transport Proteins/physiology , Syndrome , Thyroid Gland/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...